PATENT CLAIM ANALYSIS

Application Number: 16130325
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["424", "444000"]

Abstract:
The present invention provides novel methods of mimicking epinephrine plasma pharmacokinetic parameters/plasma epinephrine levels of an at least one l-epinephrine injection in humans with an at least one dosage of a sublingual l-epinephrine formulation; and includes methods of maintaining constant elevated plasma epinephrine level(s) by the consecutive dosing of sublingual l-epinephrine. These methods are especially important when l-epinephrine injection is not available or not possible. The present invention allows small, l-epinephrine sublingual tablets to be carried by soldiers and others, such as in a remote location or battlefield, when emergency medical services are not readily available or accessible. The inventive methods can sustain life and restore proper blood perfusion when someone is having cardiopulmonary difficulty until medical help or transport can arrive.

Claim (Index 8):
The method of  claim 1  whereby said at least one sublingual l-epinephrine formulation is in sublingual tablet form.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 97.0
- Lexical Diversity: 1.54651
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15262961', '15288745', '15266843', '15882399', '15596440']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7265004027872253
- 35 USC 102 Novelty (BERT): 0.5083369479862776
- Combined Prediction Score: 0.7046840573071306
- Mean Citation Score: 252.491604
- Max Citation Score: 279.46783
- Similarity Product: 208.898222429508

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test